ANVS Return on Tangible Equity | Annovis Bio, Inc.

Annovis Bio, Inc. (ANVS) Return on Tangible Equity

2026-06-30: Return Tang Equity 1164.01%.
2026-03-31: Return Tang Equity -1309.11%.
2025-12-31: Return Tang Equity -171.23%.
2025-09-30: Return Tang Equity -189.15%.

Complete source-backed return tang equity history.

Available history: 2019-12-31 to 2026-06-30
Data captured: 2026-09-04

Historical Return Tang Equity

Date	Return Tang Equity
2026-06-30	1164.01%
2026-03-31	-1309.11%
2025-12-31	-171.23%
2025-09-30	-189.15%
2025-06-30	-165.08%
2025-03-31	-120.81%
2024-12-31	-264.20%
2024-09-30	-579.57%
2024-06-30	2456.89%
2024-03-31	1417.22%
2023-12-31	725.14%
2023-09-30	-626.55%
2023-06-30	-161.18%
2023-03-31	-148.15%
2022-12-31	-89.43%
2022-09-30	-67.98%
2022-06-30	-51.55%
2022-03-31	-38.69%
2021-12-31	-32.56%
2021-09-30	-22.09%
2021-06-30	-17.35%
2021-03-31	-188.18%
2020-12-31	-72.43%
2020-09-30	-43.40%
2020-06-30	-33.76%
2020-03-31	-11.61%
2019-12-31	11.55%

Annual Return Tang Equity

Date	Return Tang Equity
2025-12-31	-171.23%
2024-12-31	-264.20%
2023-12-31	725.14%
2022-12-31	-89.43%
2021-12-31	-32.56%
2020-12-31	-72.43%
2019-12-31	11.55%

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
HERON THERAPEUTICS, INC. /DE/ (HRTX)	United States	$0.055B	-2.38
Clene Inc. (CLNN)	United States	$0.054B	-1.99
NOMAD POWER SOLUTIONS, INC. (NMAD)	United States	$0.058B
Serina Therapeutics, Inc. (SER)	United States	$0.054B	-2.35
Boundless Bio, Inc. (BOLD)	United States	$0.059B	-0.88
TALPHERA, INC. (TLPH)	United States	$0.060B
CalciMedica, Inc. (CALC)	United States	$0.061B	-1.42
Xilio Therapeutics, Inc. (XLO)	United States	$0.052B
Skye Bioscience, Inc. (SKYE)	United States	$0.061B	-0.48
Rein Therapeutics, Inc. (RNTX)	United States	$0.063B	-1.76